HOME Research Insight Key Players in the Nerve Repair and Regeneration Market are Focusing on Receiving Regulatory Approvals and Mergers and Acquisitions



Key Players in the Nerve Repair and Regeneration Market are Focusing on Receiving Regulatory Approvals and Mergers and Acquisitions


The nerve repair and regeneration market is projected to reach USD 10.59 Million by 2022 from an estimated USD 5.79 Billion in 2017, at a CAGR of 12.9%. The growth of the market can be attributed to increasing number of neurological disorders, rising geriatric population, and technological advancement.

Mergers & acquisitions and regulatory approvals are the main strategies followed by key players in the nerve repair and regeneration market. Some of the leading players that adopted this strategy include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), AxoGen (US), and Polyganics (Netherlands).

Medtronic (US) is one of the leading players in the nerve repair and regeneration market. The company focuses on receiving regulatory approvals and acquisition for increasing the sales as well as to strengthen its position in the nerve repair and regeneration market. For instance, in 2017, the company received FDA approval for the Intellis Platform Spinal Cord Stimulator (SCS) and in 2016, the company received FDA approval for its Specify SureScan MRI surgical leads. The company also focuses on acquisition to enhance its presence and increase its nerve repair and regeneration product portfolio. In 2014, the company acquired Sapiens Steering Brain Stimulation (Netherlands to develop new deep brain stimulation (DBS) technology.

Boston Scientific (US) is one of the major players in this market. The company focuses on organic and inorganic strategies for its growth in the market. In 2017, the company received CE Mark approval for Vercise Gevia Deep Brain Stimulation System. In 2016, it received FDA approval for its Precision Montage MRI Spinal Cord Stimulator System. In 2015, the company launched Precision Novi Spinal Cord Stimulator System in Europe and received CE Mark approval for it. The company focuses on inorganic strategies like acquisition. The company acquired Cosman Medical (US), to add the spinal cord stimulator and deep brain stimulation systems to its product portfolio.

Abbott Laboratories (US) is another leading player in the nerve repair and regeneration market. The company mainly focuses on receiving regulatory approvals and acquisitions to strengthen its position in the market. For instance, in 2016, the company received FDA approval for Proclaim Elite SCS System. Also in the same year, it received FDA approval for its Infinity DBS system and BurstDR stimulation. The company also focuses on inorganic strategies. For instance, in 2017, the company acquired St. Jude Medical (US). This acquisition helps the company to strengthen its nerve repair and regeneration products portfolio. Furthermore, the company acquired Spinal Modulation (US). This acquisition helps to expand the companys portfolio of neurostimulator products.

AxoGen (US) is one of the leading players of providing biomaterial product portfolio in the nerve repair and regeneration market. It focuses on receiving regulatory approvals to increase its customer base in the market. In 2015, the company received FDA approval for Avance Nerve Graft, used in the treatment of peripheral nerve repair.

Related Reports:

Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports